Pune: Serum Institute of India CEO Adar Poonawalla receives a shot of Covishield vaccine

"I am delighted to hear that, Covishield, a low-cost, logistically manageable & soon to be widely available, #COVID19 vaccine, will offer protection up to 90% in one type of dosage regime and 62% in the other dosage regime," Adar Poonawalla tweeted.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved